Presentation ESC 2023 Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock: ECLS-SHOCK Presenter: Holger Thiele August 28, 2023
Presentation ESC 2023 Post procedural anticoagulation after primary percutaneous coronary intervention for ST segment elevation myocardial infarction: a multicentre, randomised, double blind trial Presenter: Shaoping Nie August 28, 2023
News Conference News ESC 2023 Cardiac Arrest Centers Don’t Benefit OHCA Patients Without STEMI: ARREST Michael O'Riordan August 27, 2023
News Conference News ESC 2023 Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist Shelley Wood August 27, 2023
News Conference News ESC 2023 ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems Todd Neale August 27, 2023
News Conference News ESC 2023 Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK Caitlin E. Cox August 26, 2023
News Conference News ESC 2023 FIRE: Complete Revascularization Best Even for Elderly Patients With MI Michael O'Riordan August 26, 2023
News Conference News ESC 2023 COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury Michael O'Riordan August 25, 2023
Presentation ESC 2022 Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial Presenter: Otavio Berwanger August 29, 2022
Presentation ESC 2022 Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction Presenter: John H. Alexander August 28, 2022
News Conference News ESC 2022 ‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR Shelley Wood August 28, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Conference News ESC 2021 Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival Caitlin E. Cox September 01, 2021
Presentation ESC 2021 Influenza Vaccination after Myocardial Infarction - a randomized, double-blind, placebo-controlled, multicenter trial Presenter: Ole Fröbert August 31, 2021
News Conference News ESC 2021 IAMI: Influenza Vaccine Beneficial for Post-MI Patients Michael O'Riordan August 30, 2021
News Conference News ESC 2021 Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD Michael O'Riordan August 28, 2021
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021